RecruitingNot ApplicableNCT05829733
6-month Efficacy and Safety of Synolis VA 80/160 in Hip Osteoarthritis
6-month Evaluation of the Efficacy and Safety of Synolis VA 80/160 in the Treatment of Symptomatic Hip Osteoarthritis
Sponsor
Aptissen SA
Enrollment
70 participants
Start Date
May 27, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
Multicenter, independent study of Synolis VA 80/160 over a period of 6 months
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a medical device called SYNOLIS VA 80/160 for people with osteoarthritis, hip. The study is currently recruiting participants at 3 locations. People eligible for this study include aged 18 Years and older.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICESYNOLIS VA 80/160
SYNOLIS VA 80/160 (hyaluronic acid 80 mg, sorbitol 160 mg)
Locations(3)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05829733
Related Trials
Study of Parameters of Osteosarcopenia in Patients With Hip Fracture
NCT047306221 location
Safety and Effectiveness of the HIT Reverse HRS
NCT053573786 locations
Promoting Sleep to Alleviate Pain - Arthroplasty
NCT061455161 location
Cannabinoids for Osteoarthritis Pain Effectiveness Trial
NCT068784173 locations
Metabolic Profiling of Hematopoietic Stem Cells in Clonal Hematopoiesis (CHIP)
NCT052468131 location